Journal
FRONTIERS IN PHARMACOLOGY
Volume 11, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2020.585821
Keywords
neurodegenerative diseases; SIRT1; SIRT2; modulators; neuroprotective mechanism; resveratrol; selective pockets; sir reals
Categories
Funding
- MINECO [SAF 2016-79311-R]
- Consejeria de Educacion, Cultura y Deportes [SBPLY/19/180501/000245]
- UCLM [2020-GRIN-29101]
Ask authors/readers for more resources
Sirtuins, a group of NAD(+) dependent histone deacetylases, play a crucial role in neuroprotection and cellular senescence. They regulate crucial proteins and can be targeted for therapeutic purposes in metabolic disorders. Their modulation shows promise in treating neurodegenerative diseases associated with aging and protein homeostasis.
Sirtuins are NAD(+) dependent histone deacetylases (HDAC) that play a pivotal role in neuroprotection and cellular senescence. SIRT1-7 are different homologs from sirtuins. They play a prominent role in many aspects of physiology and regulate crucial proteins. Modulation of sirtuins can thus be utilized as a therapeutic target for metabolic disorders. Neurological diseases have distinct clinical manifestations but are mainly age-associated and due to loss of protein homeostasis. Sirtuins mediate several life extension pathways and brain functions that may allow therapeutic intervention for age-related diseases. There is compelling evidence to support the fact that SIRT1 and SIRT2 are shuttled between the nucleus and cytoplasm and perform context-dependent functions in neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and Huntington's disease (HD). In this review, we highlight the regulation of SIRT1 and SIRT2 in various neurological diseases. This study explores the various modulators that regulate the activity of SIRT1 and SIRT2, which may further assist in the treatment of neurodegenerative disease. Moreover, we analyze the structure and function of various small molecules that have potential significance in modulating sirtuins, as well as the technologies that advance the targeted therapy of neurodegenerative disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available